| DAIC

Aug. 15, 2017 – Patients undergoing percutaneous coronary intervention (PCI) at safety-net hospitals experienced similar outcomes as patients treated at non-safety-net hospitals, according to research published Aug. 7 issue of JACC: Cardiovascular Interventions. Read the abstract.

Read more about Safety-Net vs. Non-Safety-Net Hospitals Deliver Similar PCI Outcomes

Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc. (VDI) investigational device exemption (IDE) study so it can initiate its pivotal trial for its MobiusHD System for the treatment of resistant hypertension.

Read more about Vascular Dynamics to Initiate U.S. Trial for MobiusHD System for Resistant Hypertension

Aug. 10, 2017 — The American College of Radiology (ACR) developed three new guidance documents and revised 32 others to advance the science of radiology and improve the quality of service to patients.

Read more about ACR Issues New, Revised Guidance on Cardiac PET-CT, Other Radiology Topics

Aug. 15, 2017 — The U.S, Food and Drug Administration (FDA) granted market clearance for the HAART 200 Aortic Annuloplasty Device, the first annuloplasty device designed specifically for bicuspid aortic valve repair. With FDA clearance of both the HAART 300 and HAART 200 Aortic Annuloplasty Devices, BioStable Science and Engineering Inc. is now able to offer U.S. surgeons a comprehensive portfolio of aortic valve repair solutions that addresses all forms of aortic valve insufficiency.

Read more about FDA Clears Aortic Annuloplasty Device for Bicuspid Aortic Valve Repair

Read more about Hypertrophic Cardiomyopathy (HCM) Summit

Read an updated version of this article with more detail from CMS — "CMS to Cancel Mandatory Cardiac Bundled Payments and Cardiac Rehabilitation Payment Model."

Aug. 14, 2017 — The Centers for Medicare and Medicaid Services (CMS) may eliminate the cardiac rehabilitation incentive payments and orthopedic bundled payments that were planned to go into effect Jan. 1, 2018.